#HVO hVIVO – H1 TRADING UPDATE July 22, 2025 – Posted in: Blog, hVIVO (HVO)

hVIVO plc (AIM: HVO), a full-service Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, provides an unaudited trading update for the six months ended 30 June 2025 (H1 2025).   Highlights ·    Revenue of £24.2 million (H1 2024: £35.6 million), in line with expectations of £47 million for the full year ·    EBITDA margin (pre-exceptionals) of c.12% (H1 2024: 24.5%) ·    Cash of £23.3 million as at 30 June 2025 (30 June…

Continue reading

#VELA TECHNOLOGIES PLC – INVESTEE CO. ENSILICA #ENSI – TRADING UPDATE April 27, 2023 – Posted in: Blog, Vela Technologies Plc (VELA)

EnSilica (AIM: ENSI), a leading mixed signal chip maker, announces a trading update for the financial year ending 31 May 2023 (“FY23”). The Group has continued to trade strongly across the second half of FY23, delivering excellent new contract momentum, alongside completing a number of pre-existing projects in the period. As a result, the Board of Ensilica now expects the results for FY23 to significantly exceed current market expectations1 for EBITDA by approximately 30%, with revenue…

Continue reading

Open Orphan #ORPH – Name Change – Interim Results & Trading Update September 8, 2022 – Posted in: Blog, Open Orphan (ORPH)

Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces its intention to change its name to hVIVO plc, with the change expected to take effect on 26 October 2022.  The Board believes that the name change reflects the Company’s core human challenge and early clinical services business, where the hVIVO name has strong global brand recognition…

Continue reading

Venture Life Group #VLG – Half Year trading update  July 20, 2020 – Posted in: Venture Life Group (VLG)

20 July 2020 Venture Life Group plc (“Venture Life” the “Company” or the “Group”) Half Year trading update  Venture Life Group plc (AIM: VLG), a leader in developing, manufacturing and commercialising products for the international self-care market, provides an update on its performance for the six months to 30 June 2020, after a period of strong trading.  Financial Highlights: ·    Revenues increased 80% to £16.9 million (H1 2019: £9.4 million) ·    65% from organic growth and 15% from acquired growth ·    Venture…

Continue reading